17.3K(top 2%)
articles
543.2K(top 2%)
citations
3,758(top 2%)
★★ articles
279(top 2%)
★★★ articles
2.8(top 16%)
Avg IF
240(top 2%)
H-Index
402(top 2%)
G-Index
2,774
journals

Most Cited Articles of St. Michael's Hospital in 2019

TitleJournalYearCitations
RoB 2: a revised tool for assessing risk of bias in randomised trialsBMJ, The20193.8K
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsLancet, The20191.3K
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialLancet, The2019917
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial FibrillationNew England Journal of Medicine2019538
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsNew England Journal of Medicine2019538
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes MellitusCirculation2019345
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trialLancet, The2019341
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trialLancet Diabetes and Endocrinology,the2019304
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes MellitusCirculation2019283
Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort studyLancet, The2019249
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trialLancet, The2019228
Composition and Variation of the Human Milk Microbiota Are Influenced by Maternal and Early-Life FactorsCell Host and Microbe2019214
A comparison of heterogeneity variance estimators in simulated random-effects meta-analysesResearch Synthesis Methods2019207
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical TrialCirculation2019163
Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysisLancet Respiratory Medicine,the2019163
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level dataLancet Neurology, The2019156
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical TrialJAMA - Journal of the American Medical Association2019155
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysisEuropean Heart Journal2019150
DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review of Systematic Reviews and Meta-AnalysesNutrients2019144
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial InfarctionCirculation2019142
Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomesEuropean Heart Journal2019141
Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid RegurgitationJournal of the American College of Cardiology2019127
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary InterventionCirculation2019120
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trialLancet Diabetes and Endocrinology,the2019120
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME TrialCirculation2019115